Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EyeGel Plus
- Development stage
- Unknown
- Lead developer
- Farmigea
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
EyeGel Plus is an over-the-counter (OTC) lubricating ophthalmic gel developed by Farmigea for the relief of dry eye symptoms and the protection and hydration of the ocular surface. It is formulated as a combination of 5% dexpanthenol (a precursor of pantothenic acid/vitamin B5) and carbomer (a high-molecular-weight acrylic acid polymer). Carbomer acts as a tear substitute and thickening agent that mimics natural tear viscosity, forming a protective, lubricating film over the cornea and conjunctiva. Dexpanthenol supports corneal healing, cellular repair, and epithelial regeneration, making the gel particularly beneficial for patients with keratopathies, corneal erosions, or those recovering from ocular surgery.
- Brand names
- EyeGel Plus
- Other names
- carbomer + dexpanthenoldexpanthenol + carbomerEyegel Plus
Beyond the preview
Go deeper on EyeGel Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EyeGel Plus.